Moderna, Inc. (MRNA) — Stock Analysis & Fair Value

Moderna, Inc. (MRNA) trades on NASDAQ at $145.55 (US). Market cap $57.75B. P/E -18.2. P/B 8.5. ROE -39.2%. dividend yield 0.0%. 52-week range $22.28–$176.66.

Sector: Healthcare — Biotechnology.

On getValue you can run 9 valuation models on MRNA — DCF, Reverse DCF, Dividend Discount Model (DDM), Cash Flow + IRR, Normalized P/E, Industry Multiple, Piotroski F-Score and NAV — alongside a WACC calculator, up to 10 years of income statement, balance sheet and cash-flow data, peer comparison and insights.

Open the full MRNA analysis · Key metrics & insights

getValue is an analysis tool for education, not investment advice. Figures are shown as reported; model outputs depend on your assumptions.